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The presence of an ionized carboxyl group in the widely used non-steroidal anti-inﬂammatory (NSAID) drug diclofenac
potassium results in a high mobility of diclofenac and in its low sorption under conditions of slow sand ﬁltration or subsoil
passage. No diclofenac degradation was detected in pure water or sludge during one month. Tertiary treatments of wastewater
indicated that the eﬀective removal of diclofenac was by reverse osmosis, but the removal by activated carbon was less
satisfactory. This study presents an eﬃcient method for the removal of diclofenac from water by micelle–clay composites
that are positively charged, have a large surface area and include large hydrophobic domains. Adsorption of diclofenac
in dispersion by charcoal and a composite micelle (otadecyltrimethylammonium [ODTMA] and clay [montmorillonite])
was investigated. Analysis by the Langmuir isotherm revealed that charcoal had a somewhat larger number of adsorption
sites than the composite, but the latter had a signiﬁcantly larger binding aﬃnity for diclofenac. Filtration experiments on a
solution containing 300 ppm diclofenac demonstrated poor removal by activated carbon, in contrast to very eﬃcient removal
by micelle–clay ﬁlters. In the latter case the weight of removed diclofenac exceeded half that of ODTMA in the ﬁlter.
Filtration of diclofenac solutions at concentrations of 8 and 80 ppb yielded almost complete removal at ﬂow rates of 30 and
60mLmin−1. One kilogram of ODTMA in the micelle–clay ﬁlter has been estimated to remove more than 99% of diclofenac
from a solution of 100 ppb during passage of more than 100m3.
Keywords: diclofenac potassium;micelle–clay complex; wastewater treatment; removal of anti-inﬂammatory drugs; kinetic
studies of NSAID agents
1. Introduction
Since Ternes and Daughton [1,2] found the presence of
pharmaceuticals and personal care products (PPCP) in
wastewater, a signiﬁcant number of studies have been con-
ducted to determine the concentrations of a variety of
pharmaceuticals and PPCPs in river waters and wastew-
ater plants. These molecules are of wide concern because
they are used frequently and are released to the environment
in large quantities. Their physical and chemical properties
further enhance theirwidespread distribution in the environ-
ment. Low concentrations of these compounds have been
associated with endocrine disruption, bacteria resistance
and chronic toxicity [3].
Pharmaceuticals are generally excreted after being par-
tially or completely converted tometabolites with enhanced
solubility in water, but a signiﬁcant quantity of the parent
drug may also be excreted unchanged. Recent studies have
demonstrated that eliminationof high tomediumpolar phar-
maceuticals in municipal sewage treatment plants is often
∗Corresponding author. Email: dr_karaman@yahoo.com
incomplete, ranging between 60% and 90%. For example,
the study performed by Kolpin and co-workers has chron-
icled the detection of over 95 organic chemicals in US
streams and rivers [4]; 7 to 38 compounds were found in
water samples, together with their metabolites. Measured
concentrations reported in this study were generally in the
ng L−1 range. These results demonstrate the importance
of obtaining data on metabolites as well as parent com-
pounds, in order to fully understand the fate and transport
of individual pharmaceuticals in the wastewater cycle [5].
Among the most commonly used pharmaceuticals are
the non-steroidal anti-inﬂammatory drugs (NSAID), taken
to reduce inﬂammation and as analgesics to reduce pain in
conditions such as arthritis or acute injury. This class of
compounds includes acetylsalicylic acid (e.g. 836 tons in
Germany in 2001), paracetamol (e.g. 622 tons in Germany
in 2001), ibuprofen (e.g. 345 tons in Germany in 2001),
naproxen (e.g. 35 tons in England in 2000) and diclofenac
(e.g. 86 tons in Germany in 2001), which were found to be
ISSN 0959-3330 print/ISSN 1479-487X online
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ubiquitous in stream and river waters in the concentration
range of a few nanograms per litre [6].
Compared with the amount of data dealing with
the distribution of pharmaceutical residues in the envi-
ronment, very little information is available about
the fate of these residues, especially when focused
on microbial activity. This is somewhat anomalous
since it should be expected that microbial transforma-
tions play a dominant role during removal of polar,
acidic pharmaceuticals such as diclofenac (2-[(2,6-
dichlorophenyl)amino]benzeneacetic acid) in wastewater
treatment plants [6]. Inconsistent results were reported for
diclofenac. Median concentrations of diclofenac in German
streams (Elbe, Rhine and Main) rarely exceeded values of
50 ng L−1, and were restricted to small rivers that acted
as receiving waters for communal wastewater plants. The
presence of an ionizable carboxyl group results in a much
higher mobility of diclofenac than is indicated by its log
P (octanol–water distribution coeﬃcient), and in low sorp-
tion properties under the conditions of slow sandﬁltration or
subsoil passage. Thus, it is essential to establish an eﬃcient
method for the removal of diclofenac from wastewater that
should represent the most dominant sink for this drug [7].
Although water puriﬁcation techniques such as granu-
lar activated carbon could potentially remove this pollutant
from wastewater streams, the high cost involved suggests
that more attention should be given to the optimization of
current treatment processes and reduction at source in order
to reduce environmental contamination [8–10]. Generally
the methods used for wastewater treatment are:
1. Biodegradation: biological degradation (aerobic/
anaerobic by microorganisms).
2. Deconjugation: conjugates of organic compounds
such as steroid hormones have been shown to be
readily deconjugated in domestic wastewater and
within sewage treatment plants. It seems probable
that gluconoride and sulphate conjugates of drug
compounds may be degraded by the same process.
The eﬀect will be to increase the excreted contribu-
tion of the active drugs to sewage and eﬄuents.
3. Partitioning: partitioning between the aqueous and
organic biomass phases is a key component in
determining the ultimate concentrations of organic
pollutants. Compounds with high log P (lipophilic
molecules) values are known to be easily sorbed
from sludge, whereas substances with lower values
more likely remain in the aquatic phase, depend-
ing on the individual compound; moreover, sorbed
substances may also be remobilized if they are not
strongly bound.
4. Removal during sludge treatment: drugs may also be
degraded during sewage treatment processes. Many
pharmaceuticals are not thermally stable and so
might be expected to break down during processes
such as composting, as a result of the heat (as well
as chemical degradation and biodegradation).
5. Photodegradation: several pharmaceutical com-
pounds have been shown to degrade through the
action of sunlight. The most extensively studied of
these compounds is the analgesic/anti-inﬂammatory
drug diclofenac, which has been shown to degrade in
the aquatic environment by the action of ultraviolet
(UV) light [8].
In this paper we report a relatively novel method
for the removal of diclofenac potassium by ﬁlters that
include micelle–clay complexes. The micelle–clay com-
posites that we used are positively charged, have a large
surface area and include large hydrophobic domains. It
was shown by X-ray diﬀraction, electron microscopy
and adsorption experiments that the characteristics of
the micelle–clay complexes are diﬀerent from those of
organo–clay complexes which are formed by adsorp-
tion of the same organic ODTMA (octadecyltrimethylam-
monium) cation as monomers [11]. We also employed
a BDMHDA (benzyldimethylhexadecylammonium)–clay
complex for testing its performance in removing diclofenac
from wastewater. These micelle–clay composites have
already been proven useful in the removal of about 20
neutral and anionic pollutants [12–14].
2. Experimental
2.1. Materials
All chemicals were of analytical grade. The clay used was
Wyoming Na-montmorillonite SWY-2 obtained from the
SourceClaysRegistry (ClayMineral Society,USA).Quartz
sand (grain size 0.8–1.2mm) was obtained From Negev
IndustrialMinerals (Israel).ODTMAbromidewas obtained
from Sigma Aldrich. BDMHDA chloride was purchased
from Fluka Chemie (Switzerland). Diclofenac potassium
was obtained as a gift from Beit Jalah Pharmaceutical
Company (Palestine).Activated charcoal (12–20mesh)was
obtained from Sigma (USA). Deionized water was used to
prepare all solutions. Methanol and water for analysis were
bothHPLC grade and purchased fromSigmaAldrich.Mag-
nesium sulphate was purchased from Sigma Aldrich. High
purity diethyl ether (>99%) was purchased from Biolab
(Israel); orthophosphoric acid was obtained from Riedel-de
Haën (Germany).
The concentration of diclofenac in the mgL−1 range
was determined by using a Perkin Elmer Lamda 5 UV-
Visible spectrophotometer. Samples were shaken using Big
Bill (Banstaed/Themolyne, USA). The samples were cen-
trifuged in a Labofuge 200 (Heraeus Sepatech, Kendero
Laboratory Products, Germany).
A Shimadzu prominence high performance liquid chro-
matography (HPLC) system (Shimadzu Corp., Japan) was
used for HPLC–MS/MS measurements.
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The HPLC system consisted of a model 2695 HPLC
from Waters (USA) equipped with a Waters 2996 pho-
todiode array. Data acquisition and control were carried
out using Empower™ software (Waters, USA). Analytes
were separated on a 4.6mm × 150mm C18 XBridge®
column (5μm particle size) used in conjunction with a
4.6mm, 20μm, XBridge® C18 guard column. Microﬁlters
of 0.45μm porosity were normally used (Acrodisc® GHP,
Waters). A pH meter, model HM-30G (TOA Electronics
USA), was used in this study to measure the pH value of
each sample.
The wastewater treatment plant (WWTP) at Al-Quds
University collects a mixture of black, grey and storm
water. The treatment plant consists of a primary treatment
(two stage primary settling basin) and a secondary treat-
ment (activated sludge with a hydraulic retention time of
16–20 hours, coagulation and chlorination). The secondary
eﬄuent is introduced into a sand ﬁlter before entering the
ultraﬁltration (UF) membrane (hollow ﬁbre [HF] and spiral
wound [SW]). After the UF process, the eﬄuent is sub-
jected to an activated-carbon adsorbent followed by reverse
osmosis (RO) (advanced treatment). All eﬄuents at diﬀer-
entmixing ratios are used for an experimental programmeof
ﬁeld irrigation. The UF process consists of two small-scale
membrane treatment plants with a capacity of 12m3 d−1.
The ﬁrst UF unit is equipped with two 2 × 4 inch pressure
vessels with a pressure resistance up to 150 psi. Each vessel
holds two separation membranes (SW with 20 kDa cut-oﬀ,
equivalent to a 0.01μ separation rate, Nirosoft, Israel).
The designed permeate capacity of the system is 0.5–
0.8m3 h−1. Thismembrane can remove bacteria, suspended
solids, turbidity agents, oil and emulsions. The second unit
is equipped with two pressure vessels made by Vendor
(AST Technologies model number 8000 WW 1000-2M,
Israel) that houses the HF membranes with 100 kDa cut-oﬀ
(Vendor, AST Technologies, Model no. 8000-WWOUT-
IN-8080, Israel). The two units are designed to deliver
1.5m3 h−1. The RO system consists of a 1 × 4 inch pres-
sure vessel constructed with composite material having a
pressure resistance up to 400 psi.
The vessel holds two 4 inch special separation mem-
branes (thin polyamide ﬁlm with pH range 1–11, model
BW30-4040 by DOW Filmtec, USA). A membrane anti-
scaler (product NCS-106-FG) solution of phosphoric acid
disodium salt is continuously dosed to the RO feed at a
concentration of 4mgL−1 in order to prevent deposition of
divalent ions. The system is designed to remove major ions
and heavy metals. The designed RO permeate capacity of
the system is 0.45–0.50m3 h−1.
2.2. Methods
2.2.1. Micelle-clay complex preparation
The complex was prepared as described in [10]. Brieﬂy,
the micelle–clay complex was prepared by stirring 12mM
of ODTMA, or BDMHDA, with 10 g L−1 clay for 72 h.
Suspensions were centrifuged for 20min at 15000 rpm,
supernatants were discarded, and the complex was
lyophilized.
2.2.2. Batch experiments
Batch adsorption experiments were carried out for solu-
tions of diclofenac potassium in the concentrations range
50–1000mgL−1. Experiments were performed in 250mL
Erlenmeyer ﬂasks containing 0.500 g of either micelle–clay
complex or active carbon; 100mL of diclofenac potassium
solutions with known initial concentration were then intro-
duced to each ﬂask. The ﬂasks were shaken in an electric
shaker for 3 h at room temperature; then the content of each
ﬂask was centrifuged for 5min and ﬁltered using a 0.45μm
Milliporeﬁlter. The equilibriumconcentrationof diclofenac
potassium was then obtained spectrophotometrically. The
kinetic study of the extent of adsorption was determined by
measuring the absorbance over time of a 100mL of solu-
tion containing 200mgL−1 diclofenac potassium in 250mL
Erlenmeyer ﬂasks addedwith 0.500 g of eithermicelle–clay
complex or active carbon.
2.2.3. Column experiments
Column ﬁlter experiments were performed with 100:1 and
50:1 (w/w) mixtures of quartz sand and ODTMA– or
BDMHDA–clay complex (20 cm layer) in a column of
25 cm length and 5 cm diameter. For both 100:1 and 50:1
mixtures the active component layer in the ﬁlter included
either 6.5 or 13.0 g of the complex, corresponding to 2
or 4 g of ODTMA or BDMHDA cations, respectively.
The bottom of the column was covered with a 3 cm layer
of quartz sand. The quartz sand was thoroughly washed
with distilled water and dried at 105 ◦C for 24 h. In some
experiments the columns included 2 or 4 g of activated
carbon mixed with sand as above. Solutions of varying
diclofenac potassium concentrations (0.01, 0.1, 50, 100,
200, 300 and 1000mgL−1) were prepared by dilution of
the stock solution with distilled water. These solutions were
passed through the above columns. The ﬂow rate was var-
ied between 2.0mLmin−1 to 60mLmin−1. Fractions were
collected for assays of diclofenac potassium content.
2.2.4. HPLC–MS/MS measurements
Chromatographic separation was achieved on a Shimadzu
prominence HPLC system equipped with: a degasser
(DGU-20A3), two solvent delivery units (LC-20 AD), an
auto-sampler (SIL 20ACHT) and a columnoven thermostat
operated at 30 ◦C (CTO-20 ASVP). Separation was per-
formed using a Comosil column (5C18-MS-II), 150mm ×
4.6mm i.d., 5μm particle size (Nacalai USA, Inc.). The
mobile phase was 85% methanol and 15% water with
0.1% acetic acid at a ﬂow rate of 1mLmin−1. The sample
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volume injectedwas 50μL and theminimum concentration
calibrated was 2μL−1.
The HPLC system was coupled to a 3200 TRAP
LC/MS/MS mass spectrometer (Applied Biosystems, MDS
Sciex, USA) with an electrospray Turbo V ionization
source. Acquisition was performed in the multiple reaction
monitoring mode (MRM). Source conditions were estab-
lished as follows: ion spray (IS) voltage, 5.0 kV (ESI+),
collision gas, medium, curtain gas, 50 kPa; ion source gas
1 (GS 1, nebulizer gas) and 2 (GS 2, turbo gas), 80, 90 kPa
respectively, ion source temperature, 650 ◦C. High purity
nitrogen (>98%) was produced by NitroGen 3G (Peak Sci-
entiﬁc, USA) and used as desolvation, nebulization and
collision gas. Optimization of MS/MS parameters was
obtained by direct infusion, at 10μLmin−1, of 100 ngmL−1
diclofenac standard solutions in 50% methanol aqueous
solution.
Declustering potential (DP), collision energy (CE) and
cell exit potential (CXP) voltages were established for each
MRM transition. These values are displayed in Table 1.
All data were acquired and processed using Analyst 1.5.1
software (USA).
Table 1. Diclofenac dependent MS/MS parameters optimized
for the MRM acquisition mode.
MRM transition DP (V) CE (V) CXP (V)
296/250 31 19 4
296/215 36 23 4
2.2.5. Analysis of adsorption isotherms
Equilibrium relationships between adsorbent and adsorbate
were analysedby the linear formof theLangmuir adsorption
isotherm [15]:
Ce/Qe = 1/(k Qmax) + Ce/Qmax (1)
in which Ce (mgL−1) is the equilibrium concentration of
diclofenac potassium, Qe (mg g−1) is the equilibrium mass
of adsorbed diclofenac potassium per gram of complex or
charcoal, k (Lmg−1) is the Langmuir binding constant,
and Qmax (mg g−1) is the maximum mass of diclofenac
potassium removed per gram of complex.
Figure 1. Flow diagram showing the process of the WWTP, which consists of HF-UF ﬁlters (hollow ﬁbre) and SW-UF (spiral wound),
activated carbon and RO ﬁlters. Sampling locations are indicated by the numbers.
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2.2.6. Preparation of sample and standards for stability
and spiking studies
(a) Stock solution. Five hundred millilitres of stock
solution was prepared by dissolving 100mgL−1
diclofenac potassium standard in acetonitrile in
water (pH adjusted to 2.5) at a 65:35 ratio. This
stock solution was used in (b).
(b) Calibration curves. The following solutions were
prepared from the stock: 5, 10, 20, 40, 60, 80 and
100mgL−1.
(c) Stability study in pure water. For the stability study
of diclofenac potassium in purewater, a 100mgL−1
solution was used. The reaction progress was fol-
lowed by HPLC.
(d) Stability study in the presence of sludge. The same
diclofenac concentration as in (c) was used for
the stability study of the active substance in the
presence of sludge suspended in water. Samples at
speciﬁc time intervals were collected and the liquid
phase was extracted three times with ether.
(e) Wastewater spiking and sampling. An amount of
32 g of diclofenac potassium was dissolved in
methanol and placed into a 500 L tank containing
activated sludge eﬄuent. Then seven wastewater
samples were collected from diﬀerent locations of
the WWTP (Figure 1) using precleaned 500mL
amber glass bottles. Samples were kept on ice
during transport to the laboratory. Once received,
conventionalwastewater parameters including tem-
perature and pH were measured. The samples were
then ﬁltered and stored at 4 ◦C until extraction.
These sampleswere collected for observing the eﬃ-
ciency of removal by UF (HF and SW) membranes,
followed by activated carbon and RO membranes.
2.2.7. Diclofenac potassium sample extraction
A liquid–liquid extraction procedure was applied to the
diluted solutions (used for the calibration curve) and
wastewater samples by means of diethyl ether as solvent.
Each sample was extracted three times. The ether extracts
were combined, dried with anhydrous MgSO4, ﬁltered and
evaporated. For HPLC-PDA analysis, the dried residue,
after the ether evaporation, was dissolved in a mixture of
acetonitrile:water (65:35, adjusted to pH 2.5) and then ﬁl-
tered through 0.45mm ﬁlter before being injected to the
HPLC apparatus.
2.2.8. Chromatographic conditions
After treatment by liquid–liquid extraction, the wastewa-
ter samples were analysed using HPLC-PDA. The optimal
HPLC conditions found for the analysis of diclofenac
potassium were: C-18 as the separation column; a mix-
ture of water: acetonitrile (pH adjusted to 2.5 using dilute
o-phosphoric acid) (35:65, v/v) as a mobile phase; a ﬂow
rate of 1.0mLmin−1; UV detection at a wavelength of
289 nm.
3. Results and discussion
3.1. Spiking experiment
3.1.1. Kinetic studies on the stability of diclofenac
potassium in pure water and wastewater
The monitoring of diclofenac potassium stability in pure
water and in sludge revealed no degradation during more
than one month of standing at ambient temperature. These
ﬁndings indicate that diclofenac potassium is resistant to
water hydrolysis and bacterial degradation.
3.1.2. The eﬃciency of HF-UF, SW-UF, activated carbon
and RO membranes in the removal of diclofenac
Table 2 summarizes the results of the eﬃciency of HF-UF,
SW-UF, activated carbon and RO membranes in remov-
ing diclofenac-from waste water after secondary treatment.
The eﬃciency of the ultraﬁltration process is about 30–75%
(sample no. 4 and 5, see also Figure 1) in the removal of
diclofenac from the eﬄuent samples. On the other hand,
both the activated carbon adsorbent and the RO mem-
brane were signiﬁcantly superior to UF in the removal
of diclofenac potassium. A removal of about 95–100%
was observed by both-ﬁlters (sample no. 7 and 8, see also
Figure 1).
3.2. Batch adsorption
3.2.1. Eﬀect of contact time
Figure 2 demonstrates a rapid decrease in the absorbance
of diclofenac potassium in the presence of either charcoal
or a micelle (ODTMA)–clay (montmorillonite) complex in
dispersion. This indicates that most of the adsorption of
diclofenac was accomplished within several minutes.
3.2.2. Eﬀect of initial concentration
Table 3 summarizes the percentage removal of diclofenac
as a function of initial concentration using ODTMA–clay
complex and charcoal. The results indicate that for both
adsorbents the per cent removal of diclofenac decreases as
the initial concentration increases.
3.2.3. Adsorption isotherms
Figure 3 shows a linear relation between Ce/Qe and Ce,
indicating that the adsorption of diclofenac potassium by
the micelle (ODTMA)–clay complex obeys the Langmuir
isotherm model (Equation (1)). A similar pattern was seen
for the case of charcoal.
Thevalues ofQmax andkwere determined from the slope
and intercept in Figure 3. These values for the micelle–clay
complex are 153.8mg g−1 and 0.07 Lmg−1, respectively,
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Table 2. Removal of diclofenac from wastewater by hollow ﬁber ultraﬁltration (HF), spiral wound ultraﬁltration
(SW), activated carbon adsorbent and reverse osmosis.
Sample No. Concentration of
(see Figure 1) Name of sample location diclofenac ± SD (mg L−1)
1 Blank (before addition of 32 g of diclofenac potassium) 0
2 Initial concentration of diclofenac K before running
wastewater treatment plant
31.15 ± 0.01
3 Brine of AST-UF-HF 20.6 ± 0.1
4 Product of AST-UF-HF 10.3 ± 0.1
5 Nirosoft-UF (SW ﬁbre) ‘concentrate’ 8.5 ± 0.1
6 Permeate of Nirosoft-UF (SW ﬁbre) 3.7 ± 0.03
7 Product of activated carbon adsorbent 0.19 ± 0.01
8 Product of RO 0
Figure 2. Adsorption of diclofenac on active carbon and
micelle–clay complex as a function of time (min) at room
temperature (25 ◦C).
Table 3. Percentage removal of diclofenac from dispersions by
micelle–clay, in which the surfactant was ODTMA, or activated
carbon as a function of initial concentration after incubation for
3 h at a temperature of 27 ◦C.
Percentage removal (%)
Initial concentration
(mgL−1) Micelle–clay complex Activated carbon
200 98.5 ± 0.5 100 ± 0.5
300 96.6 ± 0.6 99.8 ± 0.6
700 87.1 ± 1 93.2 ± 1
900 77.8 ± 1 –
1000 73.4 ± 1 78.6 ± 1
whereas the values for charcoal are 158.7mg g−1 and
1.2 × 10−3 Lmg−1, respectively. The implication is that, on
a w/w basis, there are about 3% more sites for adsorption of
diclofenac on charcoal than on the micelle–clay complex,
but the aﬃnity coeﬃcient of the complex is 58-fold higher
than that of charcoal.Considering that the value of the cation
exchange capacity of montmorillonite is 0.8mmol g−1 and
the fact that the clay comprises 0.692 of the weight of
the micelle (ODTMA)–montmorillonite, it follows that the
Figure 3. Langmuir plot for the adsorption of diclofenac by
micelle (ODTMA)–clay complex. Conditions as in Table 3.
number of adsorption sites on the complex (which are posi-
tively charged) is 0.55mmol g−1 complex. Considering the
molecular weight of diclofenac, 295Da, the above value is
close to that deduced from Qmax, which is 0.52mmol g−1.
A conversion of the value obtained for k (0.070 Lmg−1)
yields 21,000M−1, which is about 10-fold higher than the
values recorded in [12] for this complex, e.g. for acetochlor
and alachlor, k = 1500 and 1000M−1, respectively.
It should be emphasized that the main reason for not
seeing diﬀerences between the charcoal and by the micelle
clay in the kinetics of diclofenac adsorption (Figure 2) is
that the process involves centrifugation for several minutes,
during which adsorption still proceeds.
3.3. Filtration results
3.3.1. Estimates of ﬁlter capacity for high initial
diclofenac concentrations
In the ﬁrst stage we obtained an estimate for the capac-
ity of the ﬁlter, which included 13.0 g of the micelle
(ODTMA)-clay complex with 4.0 g of ODTMA, to remove
diclofenac fromwater. Figure 4 demonstrates that for an ini-
tial diclofenac concentrationof 1000mgL−1 all 20portions,
50mL each, resulted in complete removal of diclofenac.
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Figure 4. Concentration of emerging diclofenac vs fractions of
diclofenac potassium at an initial concentration of 1000mgL−1
and a volume of 1000mL. Flow rate: 2mLmin−1.
This implies that at the end of this experiment the ﬁl-
ter included 0.8 g of adsorbed diclofenac per 4.0 g of the
organic cation ODTMA in the ﬁlter, or 20% w/w. After this
stage several other solutions were added and their removal
was monitored. The total amount of diclofenac retained
by these additional solutions, at concentrations between 50
and 200mgL−1, was another 0.1 g, representing a removal
≥85%.
3.3.2. Eﬀect of ﬂow rate
The ﬂow rate applied for the results in Figure 4 was rather
low, 2mLmin−1. We tested the eﬀect of an increase in
the ﬂow rate from 2mLmin−1 to 20mLmin−1. The out-
come (not shown) was a moderate reduction (about 10%)
in the capacity between the extreme cases (2mLmin−1 and
20mLmin−1). In subsequent experiments, we employed a
ﬂow rate of 20mLmin−1 and more.
3.3.3. Breakthrough curves: comparison between
micelle–clay and activated carbon ﬁlters
Figure 5 compares the eﬃciency and capacity of ﬁlters
based on activated carbon and on two types of micelle–
clay complexes, for a 300mgL−1 solution of diclofenac
potassium. The most eﬃcient ﬁlter was the one composed
of a mixture of 650 g of sand and 6.5 g of the micelle
(ODTMA)–montmorillonite complex, or 2.0 g of ODTMA.
For up to 1.5 Lof eluent, this ﬁlter yielded complete removal
of diclofenac, whereas, after elution of 3 L, the removal
was maintained at 93%. The ﬁlter that included BDMHDA
yielded 93% removal for the passage of less than 0.5 L,
whereas, at 3 L, less than 10% of diclofenac was removed.
Furthermore, the removal of diclofenac by BDMHA–clay
complex was accompanied by the appearance of very tur-
bid ﬁltrates indicating the possible decomposition of the
complex. For the activated carbon ﬁlters the removal eﬃ-
ciency was rather poor, consistent with the low capability
Figure 5. Emerging concentrations of diclofenac from ﬁlters
including activated carbon ormicelle–clay complexes inwhich the
organic cation was ODTMA or BDMHDA. The ﬁlters included
excess sand (100:1, w/w). The mass of the active ingredient, i.e.
ODTMA, BDMHDA or activated carbon, was 2 g in all cases.
T, 25 ◦C; ﬂow rate, 20mLmin−1; initial diclofenac potassium
solution concentration, 300mgL−1.
of such ﬁlters in the removal of anionic and certain neutral
pollutants [16–18].
Of note is the fact that the removal of several pollu-
tants from dispersion or by ﬁltration was either the same
or more eﬃcient by a micelle–clay complex based on
BDMHDA than by a complex that included ODTMA [12].
This was attributed to interactions between the benzene
rings of BDMHDA and the neutral or anionic pollutants
considered, in accordance with a previous ﬁnding in the
case of organo-clays [19]. The variance of the obtained
results for diclofenac could be explained by the observa-
tion that binding of diclofenac with the micelle on the clay
leads to a destabilization of the complex, thereby lead-
ing to the observed decomposition. The estimated weight
of diclofenac that can be removed from a solution of
300mgL−1 is about 1 g for the ODTMA–clay ﬁlter, or 50%
of the weight of the organic cation ODTMA. The results
of this work suggest that the removal of diclofenac by a
micelle (ODTMA)–montmorillonite is promising. Hence,
it was of interest to further examine this issue for diclofenac
concentrations in the μg L−1 range.
3.3.4. Filtration in the μgL−1 range
In these experiments we employed two systems, each con-
sisting of two columnﬁlters in series. Each column included
amixture of 650 g sandwith 6.5 g of themicelle (ODTMA)–
montmorillonite complex or 2 g of ODTMA. This complex
gave the best outcome in previous ﬁltration experiments at
large concentrations of diclofenac potassium. Experiments
were carried out in four stages: (1) passage of 46 L of a
solution with 118μg L−1 of diclofenac; (2) passage of 45 L
of a solution with 8μg L−1 of diclofenac; (3) passage of
60 L of a solution with 80μg L−1 of diclofenac; in these
stages the ﬂow rate was 30mLmin−1; (4) passage of 70 L
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Table 4. Filtration of diclofenac potassium in the μg L−1 range. Emerging concentrations of diclofenac from two
ﬁlters in series including a micelle–clay complex in which the organic cation was ODTMA.a
Column 1 Column 2
Initial concentration Flow rate Vol. Diclofenac Removed Diclofenac Removed
(μg L−1) (mLmin−1) (L) (μg L−1) (%) (μg L−1) (%)
118 30 20 0 100 0 100
118 30 46 100 0 100
8 30 71 0 100 0 100
8 30 91 0 100 0 100
82 30 101 0.2 99.8 0 100
82 30 116 0.4 99.6 0.2 99.8
82 30 151 0 100 0 100
80 60 221 0 100 0 100
aThe ﬁlters included excess sand (100:1, w/w). The weight of the active substance, i.e. ODTMA, was 2 g per ﬁlter, and
ﬁltration was at room temperature. The estimated experimental uncertainty was 0.2μg L−1.
of a solution with 80μg L−1 of diclofenac at a ﬂow rate of
60mLmin−1. The results are shown in Table 4.
These results demonstrate that a ﬁlterwhich includes the
micelle (ODTMA)–montmorillonite complex is very eﬃ-
cient in removing diclofenac from water. An underestimate
of the capacity of the ﬁlter, for purifyingwaterwith an initial
diclofenac concentration of 80μg L−1 at 99% removal, is
obtained by counting the ﬁltered volume of 8μg L−1 (stage
2) as one tenth of that at 80μg L−1 and considering the
concentration of diclofenac in stage 1 as 80μg L−1. This
estimate gives a capacity of 180 L per 2 g of ODTMA, or
90m3 kg−1 of ODTMA. A more realistic estimate may be
that 100m3 of 80μg L−1 diclofenac (100 ppb of diclofenac
potassium) can be puriﬁed by 1 kg of ODTMA. The actual
estimate would be signiﬁcantly larger when using larger
ﬁlters. It can be argued that in addition to diclofenac potas-
sium the water usually includes additional pollutants. In
such cases the ﬁltration can proceed in two stages. In the
ﬁrst stage a ﬁlter based on activated carbon will remove the
majority of the neutral pollutants. This ﬁlter is not eﬃcient
in removing anionic pollutants, such as diclofenac. How-
ever themicelle–clayﬁlterwill remove these pollutants very
eﬃciently in the second stage.
4. Conclusion
An advanced wastewater treatment plant utilizing UF, acti-
vated carbon and RO showed that UF is not eﬃcient in
removing the commonly used anti-inﬂammatory and anal-
gesic diclofenac potassium from wastewater. However,
activated carbon and RO were shown to be eﬃcient. A ﬁlter
that includes a micelle (ODTMA)–montmorillonite com-
plex can purify water when this NSAID agent is present in
the ppm or ppb range. The large eﬀectiveness and removal
capacity is due to a relatively high aﬃnity of adsorption of
the anionic diclofenac by the relatively large number of pos-
itively charged and hydrophobic sites of the micelle–clay
complex based on ODTMA.
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